Literature DB >> 32863597

Underlying domains of anxiety trait in a Costa Rican sample: preliminary results.

Daniela Ugalde-Araya1, Carolina Coto-Vílchez1, Alejandro Ávila-Aguirre1, Gabriela Chavarría-Soley2,1, Henriette Raventós2,1, Javier Contreras1.   

Abstract

BACKGROUND: Imprecision of the psychiatric phenotype might partially explain the failure of genetic research to identify genes that contribute to susceptibility of anxiety disorders. Previous research concluded two underlying constructs, worry and rumination, might explain anxiety sub-syndromic symptoms in Costa Rican patients with history of mania. The goal of the current study is to explore the presence of latent constructs for quantitative anxiety in a group of subjects with a wide diagnostic phenotype and non-affected individuals.
METHODS: We conducted an exploratory factor analysis of anxiety trait in 709 subjects. Our sample was comprised by 419 subjects with psychiatric disorders and 290 non-affected individuals. We used principal factors extraction method with squared multiple correlations of the STAI (trait subscale).
RESULTS: We found the following preliminary results: a three-factor solution with a good simple structure and statistical adequacy was obtained with a KMO of 0.92 (>0.6) and Bartlett's Test of Sphericity of 5644,44 (p<0.05). The STAI items were grouped into three factors: anxiety-absent, worry and rumination based on the characteristics of the symptoms.
CONCLUSION: Two underlying constructs, worry and rumination may explain anxiety sub-syndromic symptoms in Costa Rican subjects. Our proposed underlying structure of subsyndromal anxiety in individuals should be considered as an important factor in defining better phenotypic characterizations on a broader diagnostic concept. Worry and rumination as a phenotypic characterization may assist in genotyping; however, its predictive value on actual illness outcome still requires more research. The Genome-Wide QTL analysis for anxiety trait in the same sample is ongoing.

Entities:  

Year:  2020        PMID: 32863597      PMCID: PMC7453746          DOI: 10.1016/j.npbr.2020.01.001

Source DB:  PubMed          Journal:  Neurol Psychiatry Brain Res        ISSN: 0941-9500


  29 in total

1.  Early-life mental disorders and adult household income in the World Mental Health Surveys.

Authors:  Norito Kawakami; Emad Abdulrazaq Abdulghani; Jordi Alonso; Evelyn J Bromet; Ronny Bruffaerts; José Miguel Caldas-de-Almeida; Wai Tat Chiu; Giovanni de Girolamo; Ron de Graaf; John Fayyad; Finola Ferry; Silvia Florescu; Oye Gureje; Chiyi Hu; Matthew D Lakoma; William Leblanc; Sing Lee; Daphna Levinson; Savita Malhotra; Herbert Matschinger; Maria Elena Medina-Mora; Yosikazu Nakamura; Mark A Oakley Browne; Michail Okoliyski; Jose Posada-Villa; Nancy A Sampson; Maria Carmen Viana; Ronald C Kessler
Journal:  Biol Psychiatry       Date:  2012-04-21       Impact factor: 13.382

2.  Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder.

Authors:  Dean F MacKinnon; Peter P Zandi; Jennifer Cooper; James B Potash; Sylvia G Simpson; Elliot Gershon; John Nurnberger; Theodore Reich; J Raymond DePaulo
Journal:  Am J Psychiatry       Date:  2002-01       Impact factor: 18.112

Review 3.  Epidemiology of anxiety disorders.

Authors:  Ronald C Kessler; Ayelet Meron Ruscio; Katherine Shear; Hans-Ulrich Wittchen
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 4.  The size and burden of mental disorders and other disorders of the brain in Europe 2010.

Authors:  H U Wittchen; F Jacobi; J Rehm; A Gustavsson; M Svensson; B Jönsson; J Olesen; C Allgulander; J Alonso; C Faravelli; L Fratiglioni; P Jennum; R Lieb; A Maercker; J van Os; M Preisig; L Salvador-Carulla; R Simon; H-C Steinhausen
Journal:  Eur Neuropsychopharmacol       Date:  2011-09       Impact factor: 4.600

5.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Authors:  Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

6.  Only half of bipolar I and II patients report prodromal symptoms.

Authors:  Outi Mantere; Kirsi Suominen; Hanna M Valtonen; Petri Arvilommi; Erkki Isometsä
Journal:  J Affect Disord       Date:  2008-04-28       Impact factor: 4.839

7.  Is subclinical anxiety an endophenotype for bipolar I patients? A study from a Costa Rican sample.

Authors:  Javier Contreras; Elizabeth Hare; Adriana Pacheco; Michael Escamilla; Henriette Raventos
Journal:  J Affect Disord       Date:  2009-09-04       Impact factor: 4.839

8.  Perpetration of gross human rights violations in South Africa: association with psychiatric disorders.

Authors:  Dan J Stein; Stacey L Williams; Pamela B Jackson; Soraya Seedat; Landon Myer; Allen Herman; David R Williams
Journal:  S Afr Med J       Date:  2009-05

9.  Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to age 32.

Authors:  Terrie E Moffitt; Avshalom Caspi; Honalee Harrington; Barry J Milne; Maria Melchior; David Goldberg; Richie Poulton
Journal:  Psychol Med       Date:  2007-01-04       Impact factor: 7.723

10.  The protective role of trait anxiety: a longitudinal cohort study.

Authors:  W E Lee; M E J Wadsworth; M Hotopf
Journal:  Psychol Med       Date:  2006-01-05       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.